Literature DB >> 1593852

Histopathological findings in well-functioning, long-term renal allografts.

H M Isoniemi1, L Krogerus, E von Willebrand, E Taskinen, J Ahonen, P Häyry.   

Abstract

One hundred and twenty-eight patients with a first cadaveric kidney allograft participated in a prospective, randomized, clinical trial comparing triple treatment, consisting of initial low-dose cyclosporine (CsA), azathioprine (Aza) and methylprednisolone (MP), with all possible combinations of two immunosuppressive drugs. A protocol core biopsy was performed on all patients with a functioning graft two years after transplantation. The histological findings were evaluated blindly and correlated to possible risk factors for renal allograft damage. The most common histological features were diffuse fibrosis in 62% of biopsies, tubular atrophy in 64% and diffuse inflammation in 30%. Two other important findings were glomerulosclerosis (43%) and vascular intimal proliferation (36%). The histological findings were scored mostly mild. A total of 77% (69 of 89) of patients had normal or only slightly increased serum creatinine. Decreased graft function was related to increased interstitial fibrosis, inflammation, glomerulosclerosis, mesangial matrix increase of glomeruli, intimal proliferation of vessels and tubular atrophy. These findings are characteristic, but not pathognomonic, of chronic renal allograft rejection both in experimental models and in humans. Possible risk factors were correlated to graft histology. Donor age correlated strongly with mesangial matrix increase, intimal proliferation, and tubular atrophy; there was no correlation with interstitial changes. The number of acute rejections and cold ischaemia time did not correlate with any one of the histological findings at two years following transplantation. Cyclosporine dose and concentration had a negative correlation to interstitial inflammation. A "chronic allograft damage index" was eventually created for the comparison of the four different treatment groups.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1593852     DOI: 10.1038/ki.1992.21

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  16 in total

Review 1.  Calcineurin inhibitor withdrawal or tapering for kidney transplant recipients.

Authors:  Krishna M Karpe; Girish S Talaulikar; Giles D Walters
Journal:  Cochrane Database Syst Rev       Date:  2017-07-21

Review 2.  The impact of age on rejection in kidney transplantation.

Authors:  Johan W de Fijter
Journal:  Drugs Aging       Date:  2005       Impact factor: 3.923

3.  Intronic locus determines SHROOM3 expression and potentiates renal allograft fibrosis.

Authors:  Madhav C Menon; Peter Y Chuang; Zhengzhe Li; Chengguo Wei; Weijia Zhang; Yi Luan; Zhengzi Yi; Huabao Xiong; Christopher Woytovich; Ilana Greene; Jessica Overbey; Ivy Rosales; Emilia Bagiella; Rong Chen; Meng Ma; Li Li; Wei Ding; Arjang Djamali; Millagros Saminego; Philip J O'Connell; Lorenzo Gallon; Robert Colvin; Bernd Schroppel; John Cijiang He; Barbara Murphy
Journal:  J Clin Invest       Date:  2014-12-01       Impact factor: 14.808

Review 4.  Combating chronic renal allograft dysfunction : optimal immunosuppressive regimens.

Authors:  Pierre Merville
Journal:  Drugs       Date:  2005       Impact factor: 9.546

5.  Human kidney graft survival correlates with structural parameters in baseline biopsies: a quantitative observational cohort study with more than 14 years' follow-up.

Authors:  Anne R Ellingsen; Kaj A Jørgensen; Ruth Østerby; Steffen E Petersen; Svend Juul; Niels Marcussen; Jens R Nyengaard
Journal:  Virchows Arch       Date:  2020-09-28       Impact factor: 4.064

Review 6.  The pathogenesis and treatment of chronic allograft nephropathy.

Authors:  Can Li; Chul Woo Yang
Journal:  Nat Rev Nephrol       Date:  2009-07-28       Impact factor: 28.314

7.  Long-term efficacy and safety of a calcineurin inhibitor-free regimen in live-donor renal transplant recipients.

Authors:  Ahmed F Hamdy; Mohamed A Bakr; Mohamed A Ghoneim
Journal:  J Am Soc Nephrol       Date:  2008-03-12       Impact factor: 10.121

8.  Relationship between P-glycoprotein expression and cyclosporin A in kidney. An immunohistological and cell culture study.

Authors:  R García del Moral; F O'Valle; M Andújar; M Aguilar; M A Lucena; J López-Hidalgo; C Ramírez; M T Medina-Cano; D Aguilar; M Gómez-Morales
Journal:  Am J Pathol       Date:  1995-02       Impact factor: 4.307

Review 9.  Kidney allograft fibrosis: what we learned from latest translational research studies.

Authors:  Simona Granata; Claudia Benedetti; Giovanni Gambaro; Gianluigi Zaza
Journal:  J Nephrol       Date:  2020-03-19       Impact factor: 3.902

10.  The prevalence of immunologic injury in renal allograft recipients with de novo proteinuria.

Authors:  Qiquan Sun; Song Jiang; Xue Li; Xianghua Huang; Kenan Xie; Dongrui Cheng; Jinsong Chen; Shuming Ji; Jiqiu Wen; Mingchao Zhang; Caihong Zeng; Zhihong Liu
Journal:  PLoS One       Date:  2012-05-07       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.